Crinetics Pharmaceuticals, Inc. Cost of Revenue
Crinetics Pharmaceuticals, Inc. (CRNX) reported Cost of Revenue of $154.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. cost of revenue for the quarter ending 2026-06-30 was $154.00K.
- Crinetics Pharmaceuticals, Inc. cost of revenue for the quarter ending 2026-03-31 was $200.00K.
- Crinetics Pharmaceuticals, Inc. cost of revenue for the quarter ending 2025-06-30 was $0.00.
- Crinetics Pharmaceuticals, Inc. cost of revenue for the quarter ending 2025-03-31 was $0.00.
- Crinetics Pharmaceuticals, Inc. cost of revenue for fiscal 2025 was $1.08M.
- Crinetics Pharmaceuticals, Inc. cost of revenue for fiscal 2024 was $0.00.
- Crinetics Pharmaceuticals, Inc. cost of revenue for fiscal 2023 was $0.00.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|---|
| 2026-06-30 | $154.00K 10-Q · filed 2026-08-03 | $354.00K 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | $1.08M 10-K · filed 2026-02-26 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |